elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26748919-2606A22D-A3B5-406C-BC86-90A7EA0D610C
Q26748919-2606A22D-A3B5-406C-BC86-90A7EA0D610C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26748919-2606A22D-A3B5-406C-BC86-90A7EA0D610C
Targeted drugs and Psycho-oncological intervention for breast cancer patients
P2860
Q26748919-2606A22D-A3B5-406C-BC86-90A7EA0D610C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26748919-2606A22D-A3B5-406C-BC86-90A7EA0D610C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
901a61cf20e33634060b2efaecf88cb922e806a1
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer